EUVIMEDEUVIMED entdecken
Crossref

Patterns of brain metastases response to immunotherapy with pembrolizumab

Amit Mahajan, Sarah L Goldberg, Sarah A Weiss, Thuy Tran, Kanwar Singh, Kavita Joshi, Mariam S Aboian, Harriet M Kluger, Veronica L Chiang

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04754-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Amit Mahajan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and Biomedical Imaging, Yale University School of Medicine, Neuroradiology Section, CB 30, 333, Cedar St, New Haven, CT, 0651…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Antineoplastic Agents, Immunological, Brain Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Bristol-Myers Squibb, Merck, Boehringer Ingelheim.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, ImmunologicalBrain NeoplasmsCarcinoma, Non-Small-Cell LungLung NeoplasmsMelanomaAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedFollow-Up StudiesImmunotherapyRetrospective StudiesTreatment OutcomeClinical Trials, Phase II as Topic

Stichwörter der Autor:innen

CNS metastasesImmune therapyPembrolizumab

Substanzen

Antibodies, Monoclonal, HumanizedAntineoplastic Agents, Immunologicalpembrolizumab

Autor:innen und Institutionen

  • Department of Radiology and Biomedical Imaging, Yale University School of Medicine, Neuroradiology Section, CB 30, 333, Cedar St, New Haven, CT, 06510, USA. amit.mahajan@yale.edu.
  • Department of Medicine (Medical Oncology), Yale University School of Medicine, New Haven, CT, USA.
  • Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
  • Department of Radiology and Biomedical Imaging, Yale University School of Medicine, Neuroradiology Section, CB 30, 333, Cedar St, New Haven, CT, 06510, USA.
  • Department of Radiology, Children's Hospital of Philadelphia , Philadelphia, PA, USA.
  • Department of Neurosurgery, Yale School of Medicine, New Haven, CT, USA.

Förderung

  • Bristol-Myers Squibb
  • Merck
  • Boehringer Ingelheim
  • AstraZeneca United States
  • Mirati Therapeutics
  • Genentech
  • Amgen
  • Blueprint Medicine

Zitieren

APA

Mahajan, A., Goldberg, S. L., Weiss, S. A., Tran, T., Singh, K., Joshi, K., Aboian, M. S., Kluger, H. M., & Chiang, V. L. (2024). Patterns of brain metastases response to immunotherapy with pembrolizumab. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04754-8

Vancouver

Mahajan A, Goldberg SL, Weiss SA, Tran T, Singh K, Joshi K, et al. Patterns of brain metastases response to immunotherapy with pembrolizumab. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04754-8

BibTeX
@article{Mahajan2024,
  author = {Mahajan, Amit and Goldberg, Sarah L and Weiss, Sarah A and Tran, Thuy and Singh, Kanwar and Joshi, Kavita and Aboian, Mariam S and Kluger, Harriet M and Chiang, Veronica L},
  title = {Patterns of brain metastases response to immunotherapy with pembrolizumab},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04754-8}
}
Kostenlos starten →